For example, in Sarad et al.'s study, edelfosine was found to cause rapid necroptosis in apoptosis-resistant glioblastoma cells, and inhibition of RIPK1 with necrostatin-1 can eliminate edelfosine-induced necroptosis and increase the viability of cancer cells (18). Here, RIPK1 is linked to cancer.